The most widely used imaging modality for the prostate is TRUS; however, there are no clearly defined standards for the clinical approach for each individual biopsy procedure, dealing with continuous technical optimization and in particular the developments in imaging. In this review the current ...
cancer (OR: 1.28, p < 0.001) and specifically for significant prostate cancer (OR: 1.46, p < 0.001) in uni-variate analyses. However, multi-variate analyses using age, PSA, prostate volume, DRE and transrectal ultrasonography outcome, and previous biopsy (yes/no) showed that PSAV was not ...
A prostate exam is a test that checks for early signs of prostate cancer. It doesn't reveal cancer, but if the test shows an abnormal result, your doctor will likely need to take a small sample of tissue from your prostate gland (biopsy) for further testing. There are two parts to a...
Prostate biopsies incur the risk of being false-negative and this risk has not yet been evaluated for 12-core prostate biopsy. We calculated the false-negative rate of 12-core prostate biopsy and determined the patient characteristics which might affect detection rate.We included 90 prostate cancer...
The time between prostate biopsy and radical prostatectomy does not appear to have a large effect on the risk of disease recurrence, according to researchers at Memorial Sloan-Kettering Cancer Center, New York. The time between prostate biopsy and radical prostatectomy does not appear to have a ...
Patterns of visits to specialists Patients were evaluated by one of 2832 index urologists who performed the diagnostic biopsy. Including the initial diagnostic procedure and all physician visits in the subsequent 9 months, 4298, 1545, and 1552 unique urologists, radiation oncologists, and medical onco...
Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology. 2011;77(5):1035-104121420152PubMedGoogle ScholarCrossref 4. Latini DM, Hart SL, Knight SJ, et al; CaPSURE Investigators. The relationship between ...
All patients who were potent before the procedure maintained potency after the procedure. Continence levels were not compromised. Based on multi-core total prostate biopsy at 6 months, 67 % of patients were free of tumor in the targeted area and 50 % were free of disease. The authors ...
Moreover, because of the heterogeneous and multifocal nature of this disease, the likelihood of missing the lesion during the biopsy is high, with a high morbidity associated with invasive biopsy procedure41. Using our method, cells shed from the prostate into urine could be analysed instead; ...
Background: Transrectal ultrasound guided systematic biopsies of the prostate is a routine procedure to establish a prostate cancer diagnosis. However, the 10-12 prostate core biopsies only sample a relatively small volume of the prostate, and tumour lesions in regions between biopsy cores can be mi...